HepA-I
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HepA-I, covering 2026-01-16 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Booster Dose of sIPV Co-administered With MMR and HepA-I. [Phase 4]